Epic Update : Biocon

Biocon has entered into collaboration with CCM Pharmaceuticals, a subsidiary of Chemical Company of Malaysia, whereby the India’s premier biotechnology company has granted CCM an exclusive licence and distribution rights for its insulin products in Malaysia and Brunei. Both the companies are targeting an insulin market of around close to Rs 160 crore.

Get Free Penny Stock Tips,MCX Tips,Stock Tips,Forex Tips & NCDEX Tips,Commodity Tips,Share Tips,commodity tips free trial, nifty free tips,commodity trading tips, shares tips, ShareMarket Tips, Stock Market Tips, free stock tips on mobile,  Stock trading tips,Intraday Tips.